LSI is Officially Heading to Singapore — Register for LSI Asia '25 Today

Transcatheter Pulmonary Valve Devices Market Snapshot

Published March 2023 | 8 Pages | 4 Exhibits | Forecasts Through 2027

snapshot
snapshot

Order individually or subscribe and get a complete intel platform.

Overview

This market snapshot from Life Science Intelligence provides an analysis of the global market for transcatheter pulmonary valve devices. Pulmonary valve replacement is performed primarily for the treatment of pulmonary valve stenosis, a relatively rare disease associated with congenital heart defects. Devices covered within the scope of this analysis include transcatheter pulmonary valve implants for valve repair and replacement.

This market snapshot is intended to provide a high-level overview of the global market for transcatheter pulmonary valve devices, with key insights into:

  • Unit volumes from 2021 to 2027
  • Market forecasts from 2021 to 2027
  • Competitive landscape analysis of major competitors
  • Insights into key market events for strategics and startups

Companies Covered

Edwards Lifesciences

Medtronic

PolyVascular

Venus Medtech

Work with us

Accelerate your business

We’re here to help you make smarter decisions and form stronger partnerships through curated events, independent market intelligence products and services, and digital-forward media.